Boston Scientific launches brain stimulation device
Photo/Courtesy
Boston Scientific's Vercise products are designed to allow physicians an ability to control the range, shape, position and direction of electrical stimulation to treat Parkinson's.
Marlborough medical device manufacturer Boston Scientific has begun selling a brain stimulation device meant to treat the symptoms of Parkinson's disease.
The devices were approved by the Food and Drug Administration, the Marlborough medical device company said.
Boston Scientific's Vercise products are designed to allow physicians an ability to control the range, shape, position and direction of electrical stimulation to treat Parkinson's. A previous Vercise product was the first of its kind when it launched in Europe in 2015, the company said.
Vercise was first approved by the FDA in 2017 for use in the United States. Vercise works to stimulate parts of the brain through leads implanted into a small area of the brain that are powered by an implantable pulse generator to send stimulation to targeted areas.
An estimated 60,000 new cases of Parkinson’s disease are diagnosed each year, and 1.5 million Americans have the disease, according to the American Association of Neurological Surgeons.
WBJ Web Partners
Most Recent
Most Recent
0 Comments